Article info
Vasculitis
Clinical case
Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
- Correspondence to Professor Bhaskar Dasgupta; Bhaskar.Dasgupta{at}southend.nhs.uk
Citation
Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
Publication history
- Received June 16, 2015
- Revision received November 2, 2015
- Accepted November 6, 2015
- First published January 11, 2016.
Online issue publication
January 11, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/